South Korea
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 10.31 B
|
Dec. 31, 2023 | USD 97.87 | 1.09% |
|
South Korea |
|
2 |
USD 5.45 B
|
Dec. 31, 2023 | USD 166.75 | 2.20% |
|
South Korea |
|
3 |
USD 1.30 B
|
Dec. 31, 2023 | USD 698.37 | 1.93% |
|
South Korea |
|
4 |
USD 720.20 M
|
Dec. 31, 2023 | USD 125.83 | 1.12% |
|
South Korea |
|
5 |
USD 701.91 M
|
Dec. 31, 2023 | USD 24.38 | 0.88% |
|
South Korea |
|
6 |
USD 341.62 M
|
Dec. 31, 2023 | USD 42.83 | 0.90% |
|
South Korea |
|
7 |
USD 248.32 M
|
Dec. 31, 2023 | USD 177.66 | 0.74% |
|
South Korea |
|
8 |
USD 220.89 M
|
Dec. 31, 2023 | USD 64.45 | 0.31% |
|
South Korea |
|
9 |
USD 207.62 M
|
Dec. 31, 2023 | USD 13.98 | -3.04% |
|
South Korea |
|
10 |
USD 158.37 M
|
Dec. 31, 2023 | USD 1.83 | 0.74% |
|
South Korea |
|
11 |
USD 151.57 M
|
Dec. 31, 2023 | USD 28.71 | -0.56% |
|
South Korea |
|
12 |
USD 134.99 M
|
Dec. 31, 2023 | USD 104.35 | -0.50% |
|
South Korea |
|
13 |
USD 130.41 M
|
Dec. 31, 2023 | USD 38.94 | 0.04% |
|
South Korea |
|
14 |
USD 129.37 M
|
Dec. 31, 2023 | USD 26.36 | -7.63% |
|
South Korea |
|
15 |
USD 126.65 M
|
Dec. 31, 2023 | USD 89.82 | -0.84% |
|
South Korea |
|
16 |
USD 121.26 M
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
17 |
USD 108.57 M
|
Dec. 31, 2023 | USD 68.20 | 0.14% |
|
South Korea |
|
18 |
USD 98.71 M
|
Dec. 31, 2023 | USD 2.05 | 0.07% |
|
South Korea |
|
19 |
USD 97.87 M
|
Dec. 31, 2023 | USD 89.21 | -4.31% |
|
South Korea |
|
20 |
USD 88.33 M
|
Dec. 31, 2023 | USD 171.86 | 2.57% |
|
South Korea |
|
21 |
USD 84.67 M
|
Dec. 31, 2023 | USD 7.02 | 1.13% |
|
South Korea |
|
22 |
USD 84.33 M
|
Dec. 31, 2023 | USD 108.37 | -2.33% |
|
South Korea |
|
23 |
USD 68.52 M
|
Dec. 31, 2023 | USD 16.03 | -1.15% |
|
South Korea |
|
24 |
USD 68.11 M
|
Dec. 31, 2023 | USD 10.59 | -0.10% |
|
South Korea |
|
25 |
USD 64.41 M
|
Dec. 31, 2023 | USD 13.23 | 1.89% |
|
South Korea |
|
26 |
USD 62.96 M
|
Dec. 31, 2023 | USD 19.95 | 0.05% |
|
South Korea |
|
27 |
USD 59.16 M
|
Dec. 31, 2023 | USD 9.53 | 1.69% |
|
South Korea |
|
28 |
USD 58.14 M
|
Dec. 31, 2023 | USD 8.62 | 0.98% |
|
South Korea |
|
29 |
USD 56.08 M
|
Dec. 31, 2023 | USD 10.34 | -1.02% |
|
South Korea |
|
30 |
USD 51.79 M
|
Dec. 31, 2023 | USD 3.84 | 0.74% |
|
South Korea |
|
31 |
USD 51.72 M
|
Dec. 31, 2023 | USD 7.70 | -1.01% |
|
South Korea |
|
32 |
USD 51.67 M
|
Dec. 31, 2023 | USD 17.02 | -2.20% |
|
South Korea |
|
33 |
USD 47.83 M
|
Dec. 31, 2023 | USD 32.09 | 0.74% |
|
South Korea |
|
34 |
USD 41.64 M
|
Dec. 31, 2023 | USD 38.12 | 0.02% |
|
South Korea |
|
35 |
USD 40.31 M
|
Dec. 31, 2023 | USD 61.65 | 0.74% |
|
South Korea |
|
36 |
USD 39.04 M
|
Dec. 31, 2023 | USD 7.40 | 0.83% |
|
South Korea |
|
37 |
USD 38.79 M
|
Dec. 31, 2023 | USD 8.54 | 0.34% |
|
South Korea |
|
38 |
USD 38.25 M
|
Dec. 31, 2023 | USD 26.87 | -0.77% |
|
South Korea |
|
39 |
USD 37.75 M
|
Dec. 31, 2023 | USD 4.13 | 2.75% |
|
South Korea |
|
40 |
USD 37.43 M
|
Dec. 31, 2023 | USD 4.37 | 0.43% |
|
South Korea |
|
41 |
USD 37.05 M
|
Dec. 31, 2023 | USD 5.78 | -0.09% |
|
South Korea |
|
42 |
USD 36.48 M
|
Dec. 31, 2023 | USD 10.03 | -2.25% |
|
South Korea |
|
43 |
USD 35.83 M
|
Dec. 31, 2023 | USD 36.83 | -2.69% |
|
South Korea |
|
44 |
USD 34.66 M
|
Dec. 31, 2023 | USD 26.12 | -1.82% |
|
South Korea |
|
45 |
USD 33.99 M
|
Dec. 31, 2023 | USD 16.27 | 0.32% |
|
South Korea |
|
46 |
USD 33.40 M
|
Dec. 31, 2023 | USD 33.55 | -1.07% |
|
South Korea |
|
47 |
USD 31.84 M
|
Dec. 31, 2023 | USD 8.29 | 0.57% |
|
South Korea |
|
48 |
USD 30.92 M
|
Dec. 31, 2023 | USD 53.54 | 0.36% |
|
South Korea |
|
49 |
USD 30.88 M
|
Dec. 31, 2023 | USD 11.69 | 2.23% |
|
South Korea |
|
50 |
USD 28.11 M
|
Dec. 31, 2023 | USD 11.90 | 0.22% |
|
South Korea |
The Pharmaceuticals company in South Korea with the highest EBITDA is SK Inc. (KSE: 034730.KS) at USD 10.31 B.
The Pharmaceuticals company in South Korea with the lowest EBITDA is SD BioSensor, Inc (KSE: 137310.KS) at USD -192.66 M.
The top 10 Pharmaceuticals companies in South Korea by EBITDA are SK Inc., LG Chem, Ltd., Samsung Biologics Co.,Ltd., Celltrion, Inc., SK Discovery Co., Ltd., Samyang Holdings Corporation, Hanmi Pharm. Co., Ltd., Chong Kun Dang Pharmaceutical Corp., Daewoong Co., Ltd. and EASY HOLDINGS Co., Ltd..
The bottom 10 Pharmaceuticals companies in South Korea by EBITDA are SD BioSensor, Inc, HLB Co., Ltd., Ildong Holdings Co., Ltd., GeneOne Life Science, Inc., Humasis Co. Ltd., Helixmith Co., Ltd, Ildong Pharmaceutical Co., Ltd., Aprogen pharmaceuticals,Inc., CrystalGenomics, Inc. and Genexine, Inc..